alexa

GET THE APP

Editor - Chang-Guo Zhan | University of Kentucky | 5151
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Chang-Guo Zhan

Chang-Guo Zhan
Chang-Guo Zhan
Professor 
Department of Pharmaceutical Sciences
University of Kentucky
USA
University of Kentucky

Biography

Chang-Guo Zhan is Professor of Pharmaceutical Sciences in the College of Pharmacy, University of Kentucky. Dr. Zhan received a Ph.D. in Chemistry from University of Notre Dame and a Ph.D. in Science from Institute for Molecular Science (IMS), Japan. Dr. Zhan performed his postdoctoral research training as a Postdoctoral Research Scientist at Department of Medicine, Columbia University. Dr. Zhan joined the UK College of Pharmacy faculty as Associate Professor in July 2003 and was promoted to Professor in July 2007. Dr. Zhan was elected as Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2010. Dr. Zhan is a winner of 2005 Emerging Computational Technology Prize, American Chemical Society (ACS) Division of Computers in Chemistry. He has served as Chair of AAPS Computational Drug Design Focus Group and on AAPS National Biotechnology Conference Programming Committee.

Research Interest

Dr. Zhan’s main research interest is drug design and discovery through integrated computational-experimental studies. Drugs designed and discovered in Dr. Zhan’s lab are either small molecules (as inhibitors of enzymes or agonists/antagonists of receptor proteins or DNA-binding molecules etc.) or engineered proteins (mutants with significantly improved biological functions and/or increased circulation time in the body).

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Top